Skip to content
info@phixgen.com
+91-1203679147
Sequencing Partner
Search for:
Home
About Us
Rifampicin Research
24-desmethyl B
BIG-GRANT
IDENTIFYING PRODUCTION BOTTLENECKS
DEVELOPMENT OF NEW MUTANTS
Highlights
Publications
Staff
HCH Research
Academics
Inter. Conferences
Workshops
MoU
Academic Collaborators
IMiLI/IMiLI-SAC
E-journal
Articles
2023
Issue 1
Issue 2
2022
Issue-1
Issue-2
Publisher Info.
Editorial Board
About Journal
Author Guidelines
Archives
Contact
24-desmethyl rifampicin B
Scale-up and commercialization of 24-desmethyl rifampicin effective against major first-line drug (rifampicin) resistant strains of Mycobacterium tuberculosis
Work done under BIG-GRANT (BIRAC/KIIT0660/BIG-14/19).Â
Identifying Production Bottlenecks (Singhvi et al.2020, Singhvi et al. 2021, Sood et al. 2024.Â
Development of New Mutants
.